Client News
Filter by:
- Dec 21 2023 Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
- Dec 13 2023 Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List
- Dec 7 2023 Valero Energy Corporation to Announce 2023 Fourth Quarter and Full Year Earnings Results on January 25, 2024
- Dec 1 2023 Sonim Technologies to Present at the Sidoti Virtual Investor Conference December 7
- Nov 17 2023 MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering
- Nov 17 2023 MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer
- Nov 15 2023 MAIA Biotechnology Announces $4 Million Registered Direct Offering
- Nov 15 2023 Sonim Appoints Mike Mulica as Board Chair
- Nov 14 2023 Sonim Reports 34% Revenue Increase to $27.6 Million, Continued GAAP Profitability in Third Quarter 2023
- Nov 13 2023 Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology